StonvexLoading…
StonvexStonvexStonvexCore line items from VET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$1.77B | C$1.55B | C$2.01B | C$3.42B |
Operating Income | C$-668.09M | C$-6.59M | C$-278.28M | C$2.05B |
Net Income | C$-653.60M | C$-46.74M | C$-237.59M | C$1.31B |
EPS (Diluted) | C$-4.25 | C$-0.30 | C$-1.45 | C$7.80 |
Total Assets | Not available | C$6.12B | C$6.24B | C$6.99B |
Total Liabilities | Not available | C$3.30B | C$3.20B | C$3.59B |
Cash & Equivalents | C$19.09M | C$131.73M | C$141.46M | C$13.84M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 152.95M | 154.34M | 162.27M | 163.23M |